Evaluation of Effectiveness and Safety of Aortic Valve Replacement in Routine Clinical Practice
NCT ID: NCT03453567
Last Updated: 2024-12-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
900 participants
OBSERVATIONAL
2018-05-10
2030-12-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TAVR
Transcatheter Aortic Valve Replacement
Valve Replacement
Aortic valve replacement
Sutureless AVR
Sutureless Aortic Valve Replacement
Valve Replacement
Aortic valve replacement
Conventional AVR
Conventional Aortic Valve Replacement
Valve Replacement
Aortic valve replacement
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Valve Replacement
Aortic valve replacement
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patient with aortic valve replacement
Exclusion Criteria
* Acute bacterial endocarditis within 1 month of valve replacement
19 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
CardioVascular Research Foundation, Korea
OTHER
Seung-Jung Park
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Seung-Jung Park
Professor, Division of Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Suk-Jung Choo, MD
Role: PRINCIPAL_INVESTIGATOR
Asan Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sejong Hospital
Bucheon-si, , South Korea
Asan Medical Center
Seoul, , South Korea
Pusan National University Yangsan Hospital
Yangsan, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AMCCV2018-04
Identifier Type: -
Identifier Source: org_study_id